期刊文献+

血浆脑钠肽水平与慢性左心衰患者心功能远期预后的关系 被引量:5

血浆脑钠肽水平与慢性左心衰患者心功能远期预后的关系
下载PDF
导出
摘要 目的:脑钠肽(BNP)是主要由心室分泌的一种多肽类激素,其对慢性左心衰患者心功能远期预后评估的价值尚未确定,本研究旨在探讨脑钠肽对慢性左心衰患者心功能远期预后的预测价值。方法:选择2005年1月~2006年1月以"慢性左心衰"收住入院的患者80例,经住院治疗后心功能改善,临床症状好转出院,随访1年,随访率100%。比较两组不同BNP水平变化患者的远期随访结果。结果:高浓度BNP心衰患者较低浓度BNP心衰患者的远期死亡率高,两者有显著性差异(P<0.005)。结论:脑钠肽对慢性左心衰患者心功能远期预后有极高的预测价值。 Objective:Brain natriuretic peptide(BNP) secreted mainly by the ventricles of a peptide hormone, the value of assessment of long - term prognosis in patients with chronic left heart failu has not been established, this study aimed to explore the brain natriuretic peptide on cardiac function in patients with chronic left heart failure long - term prognosis of the predictive value. Methods:Choose our hospital 80 cases of patients with chronic left heart failure in January 2005 - January 2006, the cardiac function improved after hospitalization, clinical symptoms improved and discharged, 1 year follow - up, Follow - up rate 100%. Compare. two different sets of changes in BNP levels in patients with long - term follow - up results. Results: High concentrations of BNP in patients with heart failure have more long - term mortality rates than low concentration of BNP in patients with heart failure, there is a significant difference between the two sets ( P 〈 0. 005 ). Conclusion: Brain natriuretic peptide has a high predictive value on long -term prognosis of cardiac function in patients with chronic left heart failure.
作者 杜湘云
出处 《中国社区医师(医学专业)》 2010年第13期165-165,167,共2页
关键词 脑钠肽 心力衰竭 预后 BNP heart failure prognosis
  • 相关文献

参考文献7

  • 1Tsutamoto T,Wada A,Maeda K,et al.Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.Circulation,1997,96:509-516.
  • 2De Lemos JA,Marrow DA,Bentley JH,et al.The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.N Engl J Med,2001,345:1014-1021.
  • 3Ishii J,Nomura M,Nakamura Y,et al.Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.Am J Cardiol,2002,89:691-695.
  • 4Logeart D,Thabut G,Jourdain P,et al.Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.JACC,2004,43:635-641.
  • 5Loke I,Squire IB,Davies JE,et al.Reference ranges for natriuretic peptide for diagnostic use are dependent on age,gender and heart rate.Eur J Heart Fail,2003,5:599-606.
  • 6Yu CM,Sanderson JE.Plasma brain natriuretic peptide-an independent predictor of cardiovascular mortality in acute heart failure.Eur J Heart Fail,1999,1:59-65.
  • 7The Framingham Heart Study.Plasma natriuretic peptide levls and the risk of cardiovascular events and death.N Eng J Med,2004,350:655-663.

同被引文献72

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部